Pfizer Stock Analysis

PFE -  USA Stock  

USD 39.38  0.08  0.20%

The modest gains experienced by current holders of Pfizer may encourage shareholders to take a closer look at the company as it is trading at a share price of 39.38 on 9,568,376 in trading volume. The company management teams have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in May. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.04. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Pfizer stock analysis report makes it easy to digest most publicly released information about Pfizer and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Pfizer stock analysis module also helps to analyze the Pfizer price relationship with some important fundamental indicators such as market cap and management efficiency.

Pfizer Stock Analysis Notes

About 68.0% of the company shares are owned by institutional investors. The book value of Pfizer was at this time reported as 11.36. The company has Price/Earnings To Growth (PEG) ratio of 0.82. Pfizer Inc next dividend is scheduled to be issued on the 6th of May 2021. The entity had 3:1 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 78500 people. To find out more about Pfizer Inc contact Ian Read at 212 733 2323 or learn more at http://www.pfizer.com.

Pfizer Quarterly Cost of Revenue

4.21 BillionShare

Pfizer Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pfizer's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
About 68.0% of the company shares are owned by institutional investors
Latest headline from www.barrons.com: Novavaxs Covid Vaccine Is Real Competition for Pfizer and Moderna - Barrons

Pfizer Inc Upcoming and Recent Events

Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report27th of July 2021
Next Earnings Report26th of October 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End1st of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
View All Earnings Estimates

Pfizer Thematic Classifications

In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones IdeaRobots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions
Healthcare IdeaHealthcare
USA Equities from Healthcare industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 221.06 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 22.95 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 35.52 %, which entails that for every 100 dollars of revenue, it generated 0.36 of operating income.
Last ReportedProjected for 2021
Return on Investment 7.06  9.61 
Return on Average Assets 5.98  6.14 
Return on Average Equity 15.22  15.32 
Return on Invested Capital 0.24  0.22 
Return on Sales 0.39  0.35 

Management Efficiency

The entity has Return on Asset of 3.93 % which means that on every $100 spent on asset, it made $3.93 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 11.06 %, implying that it generated $11.06 on every 100 dollars invested. Pfizer management efficiency ratios could be used to measure how well pfizer inc manages its routine affairs as well as how well it operates its assets and liabilities. Pfizer Return on Average Assets are projected to increase slightly based on the last few years of reporting. The past year's Return on Average Assets were at 5.98. The current year Return on Average Equity is expected to grow to 15.32, whereas Return on Invested Capital is forecasted to decline to 0.22. Pfizer Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 35.07 Billion. The current year Tax Assets is expected to grow to about 5.8 B, whereas Goodwill and Intangible Assets are forecasted to decline to about 84.3 B.
Last ReportedProjected for 2021
Book Value per Share 10.20  10.04 
Enterprise Value over EBIT 17.25  19.97 
Enterprise Value over EBITDA 12.96  13.91 
Price to Book Value 3.95  3.64 
Tangible Assets Book Value per Share 11.87  11.54 
Enterprise Value306.7 B295 B
Tangible Asset Value66.1 B70 B

Technical Drivers

As of the 17th of June 2021, Pfizer holds the Coefficient Of Variation of 529.67, risk adjusted performance of 0.122, and Semi Deviation of 0.6902. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc information ratio, as well as the relationship between the value at risk and expected short fall to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 39.38 per share. Given that Pfizer has jensen alpha of 0.1544, we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Exponential Moving Average is calculated by weighting recent values of Pfizer Inc more heavily than older values. View also all equity analysis or get more info about exponential moving average overlap studies indicator.

Pfizer Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jennifer Damico over two weeks ago via Macroaxis 
Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3
Jennifer Damico over a month ago via Macroaxis 
Sale by Jennifer Damico of 2500 shares of Pfizer
Jennifer Damico over two months ago via Macroaxis 
Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3
Jennifer Damico over two months ago via Macroaxis 
Acquisition by Jennifer Damico of 278 shares of Pfizer subject to Rule 16b-3
Joseph Echevarria over two months ago via Macroaxis 
Acquisition by Joseph Echevarria of 1188 shares of Pfizer subject to Rule 16b-3
Jennifer Damico over two months ago via Macroaxis 
Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3
Jennifer Damico over three months ago via Macroaxis 
Acquisition by Jennifer Damico of 354 shares of Pfizer subject to Rule 16b-3
Jennifer Damico over three months ago via Macroaxis 
Exercise or conversion by Jennifer Damico of 9886 shares of Pfizer subject to Rule 16b-3
Rady Johnson over three months ago via Macroaxis 
Payment of 6422 shares by Rady Johnson of Pfizer subject to Rule 16b-3
Rady Johnson over three months ago via Macroaxis 
Exercise or conversion by Rady Johnson of 25165 shares of Pfizer subject to Rule 16b-3
Frank DAmelio over three months ago via Macroaxis 
Exercise or conversion by Frank DAmelio of 163334 shares of Pfizer subject to Rule 16b-3
Jennifer Damico over three months ago via Macroaxis 
Acquisition by Jennifer Damico of 1765 shares of Pfizer subject to Rule 16b-3

Pfizer Outstanding Bonds

Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MaturityCouponRating
026609AC1 7.25%03/01/20237.25
AA
717081AQ6 4.65%03/01/20184.65
AA
717081CY7 7.2%03/15/20397.2
AA
717081DA8 5.35%03/15/20155.35
AA
717081DB6 6.2%03/15/20196.2
AA
717081DD2 0.9%01/15/20170.9
AA
717081DE0 4.3%06/15/20434.3
AA
717081DG5 1.5%06/15/20181.5
AA

Pfizer Predictive Daily Indicators

Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pfizer Forecast Models

Pfizer time-series forecasting models is one of many Pfizer's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Pfizer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin 18.38  22.15 
EBITDA Margin 29.37  29.04 
Gross Margin 79.26  75.04 
Profit Margin 22.95  21.89 
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 78500 people.

Current Pfizer Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
42.29Hold14Odds
Pfizer Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Analyst Advice Details

Pfizer Stock Analysis Indicators

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Quick Ratio0.90
Trailing Annual Dividend Rate1.52
Fifty Two Week Low29.99
Revenue Growth-7.90%
Payout Ratio122.58%
Average Daily Volume Last 10 Day24.79M
Shares Short Prior Month68.32M
Average Daily Volume In Three Month27.62M
Shares Percent Shares Out1.09%
Gross Margins79.54%
Forward Price Earnings11.55
Short Percent Of Float1.09%
Float Shares5.57B
Fifty Two Week High43.08
Fifty Day Average39.42
Enterprise Value To Ebitda16.94
Two Hundred Day Average37.31
Enterprise Value To Revenue6.02
Trailing Annual Dividend Yield3.79%
Please check Your Equity Center. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc stock analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's stock examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer stock's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's stock value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's stock price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.